Vera Therapeutics, Inc.
VERA
$37.25
$4.2512.88%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -10.67% | -5.60% | -7.96% | 81.39% | -8.09% |
| Total Receivables | -20.11% | 17.18% | -4.96% | 88.93% | 1.89% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.22% | -19.92% | 91.30% | -26.20% | -3.45% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -29.25% | -9.27% | 96.06% | -19.13% | 163.17% |
| Total Current Assets | -10.51% | -5.73% | -6.93% | 78.84% | -7.76% |
|
|
|||||
| Total Current Assets | -10.51% | -5.73% | -6.93% | 78.84% | -7.76% |
| Net Property, Plant & Equipment | -11.90% | -8.93% | -8.19% | 1.00% | 105.81% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -15.51% | 3,015.79% | -12.98% | -6.43% | -69.57% |
| Total Assets | -10.55% | -5.19% | -6.94% | 77.90% | -7.23% |
|
|
|||||
| Total Accounts Payable | 36.43% | 42.05% | 20.83% | 66.56% | -1.33% |
| Total Accrued Expenses | 20.03% | 70.81% | -29.48% | -17.67% | 69.31% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -44.68% | -28.21% | -19.69% | -20.78% | -11.53% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 24.81% | 53.26% | -13.70% | -4.13% | 43.69% |
|
|
|||||
| Total Current Liabilities | 24.81% | 53.26% | -13.70% | -4.13% | 43.69% |
| Long-Term Debt | 0.25% | 46.27% | 0.44% | 0.43% | 0.41% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -6.18% | -5.62% | -4.13% | -3.89% | 464.40% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.59% | 46.67% | -4.28% | -1.23% | 14.52% |
|
|
|||||
| Common Stock & APIC | 1.00% | 0.95% | 0.89% | 47.06% | 0.90% |
| Retained Earnings | -13.62% | -14.92% | -11.21% | -10.39% | -12.56% |
| Treasury Stock & Other | 67.17% | -19.42% | 66.41% | -62.36% | 332.00% |
| Total Common Equity | -14.82% | -12.47% | -7.30% | 99.67% | -11.84% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -14.82% | -12.47% | -7.30% | 99.67% | -11.84% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -14.82% | -12.47% | -7.30% | 99.67% | -11.84% |
|
|
|||||